Latest news with #Regero
Time of India
21 hours ago
- Business
- Time of India
Astonea Labs set to list today: Muted GMP signals flat debut
Astonea Labs is all set to debut on the BSE SME platform on Tuesday, June 3, following the completion of its Rs 37.67 crore initial public offering (IPO). The IPO, which was open for subscription from May 27 to May 29, received a modest response from investors and is now showing zero premium in the grey market, hinting at a flat listing. As per the latest grey market data, the last traded grey market premium (GMP) for Astonea Labs is Rs 0. With the IPO price fixed at the upper band of Rs 135 per share, the estimated listing price is expected to remain at Rs 135, reflecting no expected gains or losses on listing. The IPO was entirely a fresh issue of 27.90 lakh shares, and the proceeds are to be used for a mix of expansion plans, including registration in Bolivia, setting up an ointment production unit for exports, advertising, tech upgrades, working capital, and general corporate purposes. Astonea Labs, incorporated in 2017, is engaged in the contract manufacturing of pharmaceutical and cosmetic products. Its portfolio includes skincare and healthcare products under the brands "Glow Up" and "Regero", with plans to launch a new brand 'Avicel.' The company exports to markets like Iraq and Yemen and trades packaging and raw materials within the industry. The IPO was subscribed 1.79 times overall. The retail category was subscribed 1.69 times, QIB just 0.70 times, while the NII portion saw the strongest demand at 5.60 times. Despite its strong financial performance in FY24 — including a jump in net profit to Rs 3.81 crore from Rs 0.67 crore in FY23 — the lukewarm subscription and zero GMP suggest limited excitement among investors. Analysts say the SME stock's fully priced valuation and sector-specific risks may have kept some bidders on the sidelines. ( Disclaimer : Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of Economic Times)
&w=3840&q=100)
Business Standard
5 days ago
- Business
- Business Standard
Astonea Labs IPO allotment today; check latest GMP, steps to verify status
Astonea Labs IPO allotment status: The basis of allotment of shares for Astonea Labs is expected to be finalised today, Friday, May 30, 2025. The initial public offering (IPO) of Astonea Labs, which closed for subscription on Thursday, May 29, received a muted response from investors, with the offering being oversubscribed by nearly 1.8 times. Once the allotment is finalised, investors can check their status on the official websites of the BSE and Kfin Technologies, the registrar for the Astonea Labs IPO. Alternatively, investors can also follow these direct links to check the Astonea Labs IPO allotment status online: Check Astonea Labs IPO allotment status on BSE: Check Astonea Labs IPO allotment status on Kfin Technologies: Astonea Labs IPO details The SME offering, valued at around ₹37.67 crore, comprises an entirely fresh issue of 2.79 million equity shares with no offer for sale (OFS) component. The public issue was open for subscription from Tuesday, May 27, 2025, to Thursday, May 29. Astonea Labs IPO was available at the price band of ₹128 to ₹135 per share, with a lot size of 1,000 shares. Kfin Technologies serves as the registrar, while Oneview Corporate Advisors acts as the sole book-running lead manager for the offering. According to the RHP, the company aims to utilise the issue proceeds for funding of expenses proposed to be incurred towards registration in Bolivia, South America; purchase and installation of plant and machineries for ointment production for the purpose of export in accordance with the international standards and protocols, on the second floor of the existing premises; advertising, marketing and brand building; investment in procuring hardware and software and funding of working capital requirements. The remaining funds will be used for general corporate purposes. Check Blue Water Logistics IPO allotment status About Astonea Labs Incorporated in 2017, Astonea Labs is a contract manufacturer of pharmaceutical and cosmetic products for companies both within India and internationally. The company manufactures and markets a variety of pharmaceutical and cosmetic products, including antibiotics, anti-cold medicines, antihistamines, and treatments for diabetes, heart, gynecological issues, infections, and more. The company offers skin, tooth, and hair care products in forms like gels, creams, and serums, and also trades packaging and raw materials for pharmaceutical and cosmetic industries, meeting industry standards. The company engages in contract manufacturing of pharmaceutical and cosmetic products, markets its own brands Glow Up and Regero, plans to launch Avicel, and exports to countries like Iraq and Yemen.
Economic Times
27-05-2025
- Business
- Economic Times
Astonea Labs IPO opens today: Here's what you need to know before subscribing
The initial public offering (IPO) of Astonea Labs, a company engaged in manufacturing pharmaceutical and cosmetic products, will open for subscription on May 27, and close on May 29. The company is aiming to raise Rs 37.67 crore through a fresh issue of 27.90 lakh shares. It will be listed on the BSE SME platform, with a tentative listing date of June 3. ADVERTISEMENT Oneview Corporate Advisors is the book-running lead manager, and KFin Technologies is the registrar to the issue. The price band for the IPO is set at Rs 128 to Rs 135 per share. Retail investors can apply for a minimum of 1,000 shares, which requires an investment of Rs 1,35,000 at the upper price band. High-net-worth individuals (HNIs) can bid for a minimum of two lots (2,000 shares), requiring Rs 2,70,000. Founded in 2017, Astonea Labs is involved in contract manufacturing of a wide range of pharmaceutical and cosmetic products. Its offerings include antibiotics, anti-cold drugs, diabetic care, heart and gynecological medicines, as well as personal care products like gels, serums, creams, and company also markets its own brands -- "Glow Up" (skincare) and "Regero" (pharma). It plans to launch another brand called "Avicel" and exports its products to countries like Iraq and Yemen. ADVERTISEMENT The company will use the IPO proceeds for registration expenses in Bolivia, purchase of machines for ointment production, advertising and brand promotion, buying IT hardware and software, working capital needs and general corporate purposes ADVERTISEMENT Astonea Labs posted a profit of Rs 4.10 crore in the nine months ended December 2024 on a revenue of Rs 69.69 crore. The company has shown strong growth over the years with a return on equity (ROE) of 37.86% and PAT margin of 4.75%. (Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of Economic Times) (You can now subscribe to our ETMarkets WhatsApp channel)
